Reducing DNA repair protein levels to target root cause of Huntington's disease
Researchers from the Huntington's Disease Center, UCL Queen Square Institute of Neurology, and UK DRI at UCL have taken major ...
Daily drug can mimic health benefits of high-altitude, low-oxygen living for mitochondrial disease
For the average person, living at high altitude—where oxygen is sparser than at sea level—can have health benefits ranging ...
EurekAlert!1d
Daily drug captures health benefits of high-altitude, low-oxygen living
Scientists at Gladstone Institutes have developed a drug that mimics the effects of breathing low oxygen. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the HypoxyStat ...
Thiogenesis Announces Commencement of OTCQX Trading in the U.S.
Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing disulfides that drive the production of critically ...